UMass Medical School has received approximately $10 million from the Department of Defense to develop new technologies and strategies that will anticipate and predict drug resistance and susceptibility in influenza. Robert Finberg, MD, is leading the multi-disciplinary team undertaking the research.
Ronald Adler, MD, employs a patient-centered approach to care and strongly advises that physicians balance cancer screening recommendations with patient needs as a means to protect against overdiagnosis and overtreatment.
Scientists and clinicians at UMass Medical School, Wyss Institute for Biologically Inspired Engineering and the Beth Israel Deaconess Medical Center have shown in a clinical trial that a new vibration-based prevention technology reduces apneic events in prematurely born infants.
In a new study published online in The FASEB Journal, a research team led by Rita Bortell, PhD, and Agata Jurczyk, PhD, found that a shared gene (or genes) may underlie the co-occurrence of type 2 diabetes and psychiatric disorders.
By pairing the CRISPR/Cas9 system with a programmable DNA-binding domain (CRISPR/Cas9-pDBD), Scot Wolfe, PhD, has developed a new technology platform that is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes.
Neurobiologist Patrick Emery, PhD, and his research group have identified a molecular pathway responsible for how the circadian clock in fruit flies responds to changes in temperature. Published in the journal Cell on Nov. 19, his findings may have implications for humans suffering ill health related to shift work.
Timothy A. Riley, PhD, has been named associate vice chancellor for innovation and business development. He will be the chief deputy of the innovation and business development office, playing key leadership roles across all of activities.
UMMS ob-gyn expert Tara Kumaraswami, MD, welcomes new recommendations to expand prescribing of long-acting reversible contraceptives as the safest and most effective means to reduce high rates of unintended pregnancy, especially among teens.
David McManus, MD, and colleagues are working on ways to remotely and noninvasively monitor patients with serious cardiac disease in the hopes of keeping them healthier and preventing emergency room visits and hospitalizations.
Scientists at the New England Center for Stroke Research at UMass Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University are developing a drug-device combination for treating life-threatening blood clots in patients with stroke. Ajay Wakhloo, MD, PhD, co-led the study.